Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 491.5 SEK -2.09% Market Closed
Market Cap: 15.5B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Relative Value

The Relative Value of one XVIVO stock under the Base Case scenario is 204.21 SEK. Compared to the current market price of 491.5 SEK, Xvivo Perfusion AB is Overvalued by 58%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

XVIVO Relative Value
Base Case
204.21 SEK
Overvaluation 58%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
57
vs Industry
7
Median 3Y
18.6
Median 5Y
20.5
Industry
2.3
Forward
17.8
vs History
68
vs Industry
2
Median 3Y
261.5
Median 5Y
138
Industry
23
Forward
117.3
vs History
33
vs Industry
1
Median 3Y
205.7
Median 5Y
173.1
Industry
14.3
vs History
28
vs Industry
2
Median 3Y
173.1
Median 5Y
95
Industry
20
vs History
42
vs Industry
8
Median 3Y
5.4
Median 5Y
6.4
Industry
2.2
vs History
57
vs Industry
7
Median 3Y
18.2
Median 5Y
19.9
Industry
2.4
Forward
17.3
vs History
60
vs Industry
6
Median 3Y
24.5
Median 5Y
27.1
Industry
5
vs History
34
vs Industry
0
Median 3Y
240.9
Median 5Y
103.2
Industry
12.9
Forward
80.3
vs History
49
vs Industry
0
Median 3Y
305.4
Median 5Y
258.7
Industry
17.4
Forward
127.1
vs History
33
vs Industry
1
Median 3Y
202.1
Median 5Y
161.5
Industry
14
vs History
28
vs Industry
2
Median 3Y
161.5
Median 5Y
90.9
Industry
18.2
vs History
46
vs Industry
9
Median 3Y
5.5
Median 5Y
7.2
Industry
1.9

Multiples Across Competitors

XVIVO Competitors Multiples
Xvivo Perfusion AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Xvivo Perfusion AB
STO:XVIVO
15.5B SEK 20.6 75.8 265.1 265.1
JP
Hoya Corp
TSE:7741
7T JPY 8.6 35.9 23.7 28.5
CH
Alcon AG
SIX:ALC
38.2B CHF 4.3 36.2 17.8 34.4
DK
Coloplast A/S
CSE:COLO B
177.1B DKK 6.6 35.1 22.6 26.6
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 36.8 18.6 22.4
KR
HLB Inc
KOSDAQ:028300
10.3T KRW 198.6 -55.5 -85.5 -80.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51B CNY 11.5 27.6 23.9 23.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.7B USD 4.5 15.8 10.9 12.4
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.3 -17.1 16.6 55.6
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.1 264.5 462
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.5 23.2 38.1
P/E Multiple
Earnings Growth PEG
SE
Xvivo Perfusion AB
STO:XVIVO
Average P/E: 38.5
75.8
52%
1.5
JP
Hoya Corp
TSE:7741
35.9
15%
2.4
CH
Alcon AG
SIX:ALC
36.2
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.1
15%
2.3
US
Align Technology Inc
NASDAQ:ALGN
36.8
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -55.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.8
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.1 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.1
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
46.5
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
Xvivo Perfusion AB
STO:XVIVO
Average EV/EBITDA: 68.7
265.1
85%
3.1
JP
Hoya Corp
TSE:7741
23.7
15%
1.6
CH
Alcon AG
SIX:ALC
17.8
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.6
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.6
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -85.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.9
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.9
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.6
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
264.5
12%
22
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1